Results
|
|
6361.
|
Phase II trial of biweekly cetuximab and irinotecan as third-line therapy for pretreated KRAS exon 2 wild-type colorectal cancer. [electronic resource] by
- Osumi, Hiroki
- Shinozaki, Eiji
- Mashima, Tetsuo
- Wakatsuki, Takeru
- Suenaga, Mitsukuni
- Ichimura, Takashi
- Ogura, Mariko
- Ota, Yumiko
- Nakayama, Izuma
- Takahari, Daisuke
- Chin, Keisho
- Miki, Yoshio
- Yamaguchi, Kensei
Producer: 20180904
In:
Cancer science vol. 109
Availability: No items available.
|
|
|
6362.
|
|
|
|
6363.
|
Progression of Colorectal Liver Metastases from the End of Chemotherapy to Resection: A New Contraindication to Surgery? [electronic resource] by
- Vigano, Luca
- Darwish, Shadya Sara
- Rimassa, Lorenza
- Cimino, Matteo
- Carnaghi, Carlo
- Donadon, Matteo
- Procopio, Fabio
- Personeni, Nicola
- Del Fabbro, Daniele
- Santoro, Armando
- Torzilli, Guido
Producer: 20190212
In:
Annals of surgical oncology vol. 25
Availability: No items available.
|
|
|
6364.
|
Biological markers as a predictor for response and prognosis of unresectable gastric cancer patients treated with irinotecan and cisplatin. [electronic resource] by
- Nagashima, Fumio
- Boku, Narikazu
- Ohtsu, Atsushi
- Yoshida, Shigeaki
- Hasebe, Takahiro
- Ochiai, Atsushi
- Sakata, Yu
- Saito, Hiroshi
- Miyata, Yoshinori
- Hyodo, Ichinosuke
- Ando, Masahiko
Producer: 20060303
In:
Japanese journal of clinical oncology vol. 35
Availability: No items available.
|
|
|
6365.
|
A phase I clinical trial of the sequential combination of irinotecan followed by flavopiridol. [electronic resource] by
- Shah, Manish A
- Kortmansky, Jeremy
- Motwani, Monica
- Drobnjak, Marija
- Gonen, Mithat
- Yi, Sandy
- Weyerbacher, Amanda
- Cordon-Cardo, Carlos
- Lefkowitz, Robert
- Brenner, Baruch
- O'Reilly, Eileen
- Saltz, Leonard
- Tong, William
- Kelsen, David P
- Schwartz, Gary K
Producer: 20050823
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 11
Availability: No items available.
|
|
|
6366.
|
|
|
|
6367.
|
The selective poly(ADP-ribose) polymerase-1(2) inhibitor, CEP-8983, increases the sensitivity of chemoresistant tumor cells to temozolomide and irinotecan but does not potentiate myelotoxicity. [electronic resource] by
- Miknyoczki, Sheila
- Chang, Hong
- Grobelny, Jennifer
- Pritchard, Sonya
- Worrell, Candace
- McGann, Natalie
- Ator, Mark
- Husten, Jean
- Deibold, James
- Hudkins, Robert
- Zulli, Allison
- Parchment, Ralph
- Ruggeri, Bruce
Producer: 20071015
In:
Molecular cancer therapeutics vol. 6
Availability: No items available.
|
|
|
6368.
|
A pilot phase II study of chemotherapy with oxaliplatin, folinic acid, 5-fluorouracil and irinotecan in metastatic gastric cancer. [electronic resource] by
- Chiesa, Matteo Dalla
- Buti, Sebastiano
- Tomasello, Gianluca
- Negri, Federica
- Buononato, Massimo
- Brunelli, Antonio
- Lazzarelli, Silvia
- Brighenti, Matteo
- Donati, Gianvito
- Passalacqua, Rodolfo
Producer: 20070917
In:
Tumori vol. 93
Availability: No items available.
|
|
|
6369.
|
ERCC1 protein expression predicts the response of cisplatin-based neoadjuvant chemotherapy in non-small-cell lung cancer. [electronic resource] by
- Fujii, Tetsuya
- Toyooka, Shinichi
- Ichimura, Kouichi
- Fujiwara, Yoshiro
- Hotta, Katsuyuki
- Soh, Junichi
- Suehisa, Hiroshi
- Kobayashi, Naruyuki
- Aoe, Motoi
- Yoshino, Tadashi
- Kiura, Katsuyuki
- Date, Hiroshi
Producer: 20080923
In:
Lung cancer (Amsterdam, Netherlands) vol. 59
Availability: No items available.
|
|
|
6370.
|
|
|
|
6371.
|
|
|
|
6372.
|
|
|
|
6373.
|
Antiangiogenic and anticolorectal cancer effects of metronomic irinotecan chemotherapy alone and in combination with semaxinib. [electronic resource] by
- Bocci, G
- Falcone, A
- Fioravanti, A
- Orlandi, P
- Di Paolo, A
- Fanelli, G
- Viacava, P
- Naccarato, A G
- Kerbel, R S
- Danesi, R
- Del Tacca, M
- Allegrini, G
Producer: 20080610
In:
British journal of cancer vol. 98
Availability: No items available.
|
|
|
6374.
|
|
|
|
6375.
|
|
|
|
6376.
|
|
|
|
6377.
|
Bevacizumab combined with chemotherapy in the second-line treatment of metastatic colorectal cancer: results from the phase II BEVACOLOR study. [electronic resource] by
- Bennouna, Jaafar
- Borg, Christophe
- Delord, Jean-Pierre
- Husseini, Faress
- Trillet-Lenoir, Véronique
- Faroux, Roger
- François, Eric
- Ychou, Marc
- Goldwasser, François
- Bouché, Olivier
- Senellart, Helene
- Kraemer, Sandrine
- Douillard, Jean-Yves
Producer: 20120605
In:
Clinical colorectal cancer vol. 11
Availability: No items available.
|
|
|
6378.
|
Identification of a potent epigenetic biomarker for resistance to camptothecin and poor outcome to irinotecan-based chemotherapy in colon cancer. [electronic resource] by
- Miyaki, Yuichiro
- Suzuki, Koichi
- Koizumi, Kei
- Kato, Takaharu
- Saito, Masaaki
- Kamiyama, Hidenori
- Maeda, Takafumi
- Shibata, Kiyoshi
- Shiya, Norihiko
- Konishi, Fumio
Producer: 20120120
In:
International journal of oncology vol. 40
Availability: No items available.
|
|
|
6379.
|
Sensitivity to previous irinotecan treatment does not predict the efficacy of combination chemotherapy with cetuximab plus irinotecan for wild-type KRAS metastatic colorectal cancer. [electronic resource] by
- Shitara, Kohei
- Ura, Takashi
- Matsuo, Keitaro
- Takahari, Daisuke
- Yokota, Tomoya
- Yuki, Satoshi
- Yoshida, Motoki
- Utsunomiya, Setsuo
- Sato, Yozo
- Yamaura, Hidekazu
- Kato, Mina
- Inaba, Yoshitaka
- Tajika, Masahiro
- Kawai, Hiroki
- Yamazaki, Kentaro
- Komatsu, Yoshito
- Muro, Kei
Producer: 20120112
In:
European journal of cancer (Oxford, England : 1990) vol. 47
Availability: No items available.
|
|
|
6380.
|
Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. [electronic resource] by
- Wallace, Bret D
- Wang, Hongwei
- Lane, Kimberly T
- Scott, John E
- Orans, Jillian
- Koo, Ja Seol
- Venkatesh, Madhukumar
- Jobin, Christian
- Yeh, Li-An
- Mani, Sridhar
- Redinbo, Matthew R
Producer: 20101206
In:
Science (New York, N.Y.) vol. 330
Availability: No items available.
|